Skip to main content

Abstract

Objective:

The authors sought to characterize the symptoms of patients later hospitalized for psychotic disorders in primary mental health outpatient settings, and to investigate whether these symptoms can be used to predict later onset of psychotic illness.

Method:

This was a population-based historical prospective cohort study using national registers of clinical psychiatric services. The sample (N=114,983) comprised 18- to 21-year-olds serving in the Israeli military and examined in military mental health outpatient clinics across 72 consecutive months.

Results:

Overall, 1,092 individuals (0.95%) not diagnosed with a psychotic disorder at the time of examination were hospitalized for nonaffective psychotic disorder up to 9 years after the index examination. A principal components analysis of symptoms presented at index examination found that a symptom cluster of thought disorder, perceptual abnormalities, poor orientation, and suicidality was associated with an increased risk for hospitalization for nonaffective psychotic disorder within 14 days after examination (hazard ratio=45.80, 95% CI=22.87–91.73), 15–111 days after examination, (hazard ratio=19.59, 95% CI=13.08–29.33), 112–365 days after examination (hazard ratio=4.94, 95% CI=2.59–9.40), and 1–3.5 years after examination (hazard ratio=3.42, 95% CI=2.21–5.28), but not for hospitalization 3.5 years or more after examination (hazard ratio=1.57, 95% CI=0.91–2.71). Despite the increased risk, the positive predictive values of this symptom cluster were low, ranging from 0.54% to 1.99%.

Conclusions:

In 18- to 21-year-olds, the presence of psychotic symptoms was associated with later hospitalization for a nonaffective psychotic disorder. However, the low positive predictive values of symptoms elicited in primary mental health care settings suggest that symptoms alone are not useful in predicting later hospitalization for nonaffective psychotic disorder.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 351 - 358
PubMed: 29179579

History

Received: 14 December 2016
Revision received: 27 May 2017
Revision received: 2 August 2017
Accepted: 7 September 2017
Published online: 28 November 2017
Published in print: April 01, 2018

Keywords

  1. Psychosis
  2. Schizophrenia
  3. Prodrome

Authors

Details

Abigail Livny, Ph.D.
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abraham Reichenberg, Ph.D.
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eyal Fruchter, M.D.
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Rinat Yoffe, M.A.
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Shira Goldberg, M.A.
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Daphna Fenchel, M.Sc.
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Shimon Burshtein, M.D.
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eitan Bachar, Ph.D.
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Michael Davidson, M.D.
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Mark Weiser, M.D. [email protected]
From the Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel; the Departments of Psychiatry and Preventive Medicine, Friedman Brain Institute and Mindich Institute of Child Health and Development, Icahn School of Medicine at Mount Sinai, New York; the Department of Mental Health, Israeli Defense Forces Medical Corps, Ramat Gan, Israel; the Department of Psychiatry, Rambam Medical Center, Haifa, Israel; Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; the Department of Mental Health, Ministry of Health, Jerusalem, Israel; the Department of Psychology, Hebrew University, Jerusalem, Israel; and the Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Notes

Address correspondence to Prof. Weiser ([email protected]).
Presented in part at the 55th Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, Dec. 4–8, 2016.

Competing Interests

Dr. Davidson is employed by Minerva Neurosciences and has stock options. The other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share